» Articles » PMID: 29765017

Assessment of Established Techniques to Determine Developmental and Malignant Potential of Human Pluripotent Stem Cells

Overview
Journal Nat Commun
Specialty Biology
Date 2018 May 17
PMID 29765017
Citations 54
Affiliations
Soon will be listed here.
Abstract

The International Stem Cell Initiative compared several commonly used approaches to assess human pluripotent stem cells (PSC). PluriTest predicts pluripotency through bioinformatic analysis of the transcriptomes of undifferentiated cells, whereas, embryoid body (EB) formation in vitro and teratoma formation in vivo provide direct tests of differentiation. Here we report that EB assays, analyzed after differentiation under neutral conditions and under conditions promoting differentiation to ectoderm, mesoderm, or endoderm lineages, are sufficient to assess the differentiation potential of PSCs. However, teratoma analysis by histologic examination and by TeratoScore, which estimates differential gene expression in each tumor, not only measures differentiation but also allows insight into a PSC's malignant potential. Each of the assays can be used to predict pluripotent differentiation potential but, at this stage of assay development, only the teratoma assay provides an assessment of pluripotency and malignant potential, which are both relevant to the pre-clinical safety assessment of PSCs.

Citing Articles

Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy.

Gao S, Li D, Wang B, Zhang H, Chen L Front Cardiovasc Med. 2025; 12:1540066.

PMID: 40046966 PMC: 11880279. DOI: 10.3389/fcvm.2025.1540066.


Material surface conjugated with fibroblast growth factor-2 for pluripotent stem cell culture and differentiation.

Sung T, Pan Z, Wang T, Lin H, Chang C, Hung L Regen Biomater. 2025; 12:rbaf003.

PMID: 39967781 PMC: 11835233. DOI: 10.1093/rb/rbaf003.


Methods for Pluripotent Stem Cell Characterization: A Narrative Review.

Temsamani F, Agalit A, Idrissi Serhrouchni K Cureus. 2025; 17(1):e77362.

PMID: 39944459 PMC: 11815987. DOI: 10.7759/cureus.77362.


Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control.

Dobner J, Diecke S, Krutmann J, Prigione A, Rossi A Nat Commun. 2024; 15(1):8547.

PMID: 39358374 PMC: 11447164. DOI: 10.1038/s41467-024-52922-1.


Evaluating Strategies to Assess the Differentiation Potential of Human Pluripotent Stem Cells: A Review, Analysis and Call for Innovation.

Smith L, Quelch-Cliffe R, Liu F, Aguilar A, Przyborski S Stem Cell Rev Rep. 2024; 21(1):107-125.

PMID: 39340737 PMC: 11762643. DOI: 10.1007/s12015-024-10793-5.


References
1.
Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D . Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009; 33(10):1529-39. DOI: 10.1097/PAS.0b013e3181ad25d5. View

2.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

3.
Andrews P, Matin M, Bahrami A, Damjanov I, Gokhale P, Draper J . Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans. 2005; 33(Pt 6):1526-30. DOI: 10.1042/BST0331526. View

4.
Weissbein U, Schachter M, Egli D, Benvenisty N . Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq. Nat Commun. 2016; 7:12144. PMC: 4941052. DOI: 10.1038/ncomms12144. View

5.
Ng E, Davis R, Stanley E, Elefanty A . A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc. 2008; 3(5):768-76. DOI: 10.1038/nprot.2008.42. View